asthma. Asthma
Conditions
Interventions
Intervention 1: The intervention group will receive 0.5 mg ipratropium nubulized (repeated up to 3 doses in every 20 minutes) , 5 mg Albuterol inhalation and Prednisolon at the beginning (zero time po
Treatment - Drugs
The intervention group will receive 0.5 mg ipratropium nubulized (repeated up to 3 doses in every 20 minutes) , 5 mg Albuterol inhalation and Prednisolon at the beginning (zero time point). Also, 2 mg
The control group will receive 0.5 mg nebulized ipratropium (repeated up to 3 doses in every 20 minutes) , 5 mg Albuterol inhalation and Prednisolon at the beginning (zero time point).
Sponsors
Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: the age between 18 and 65 years; patients with shortness of breath; cases with a history of asthma that correlate with their clinical and paraclinical parameters Exclusion criteria: The patients with tacrolimus allergy; HCO-60 (polyoxyl 60 hydrogenated castor oil); Hyperpigmentation scars, diabetes mellitus; renal failure; heart failure; electrolyte disorders; uncontrolled blood pressure; neurologic disorders; lymphoma and other malignancies; pregnancy and breast feeding
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PEFR. Timepoint: 0,30,60,120 and 150 minutes after treatment. Method of measurement: spirometry.;FEV1. Timepoint: 0,30,60,120 and 150 minutes after treatment. Method of measurement: spirometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHasan Motamed
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed